Hilleman Laboratories
PrivateLast Round
Grant
Jan 22, 2026
Total Funding Raised
$32.14M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Hilleman Laboratories operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Grant round in January 2026.
Hilleman Laboratories is a biopharmaceutical company that develops affordable vaccines and biologics for infectious diseases prevalent in low- and middle-income countries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Quality Management
Business Model
Nonprofit or NGO
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hilleman Laboratories Comparables
Compare Hilleman Laboratories with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Access to Advanced Health Institute | 87% | |
| IAVI | 86% | |
| Bill & Melinda Gates Medical Research Institute | 84% |
For institutional investors. Book with your work email.
Hilleman Laboratories Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2026 | ||||
| Corporate Funding | Dec 6, 2021 | ||||
| Grant | Apr 1, 2021 | ||||
| Grant | Sep 28, 2017 | ||||
| Joint Venture | Sep 16, 2009 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hilleman Laboratories Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| Gates Foundation | Grant |
| Vinnova | Grant |
| Singapore Economic Development Board | Corporate Funding |
| Bill & Melinda Gates Foundation | Grant |
| Wellcome Trust | Joint Venture |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 37% MoM.
- Jul 24, 2026
Monthly visitors increased 812% MoM to 3.4K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 28, 2026
The Health Ministry hopes to work with Hilleman Laboratories Pvt. Ltd., which has its headquarters and manufacturing facility in Singapore, to develop new mRNA vaccines for pandemic preparedness.
- is_developingAug 22, 2026
Hilleman Laboratories Pvt. Ltd. is to develop the "rVSV Bundibugyo" vaccine, which targets the Bundibugyo Ebola strain and is described by the WHO as the most promising, in Singapore.
For institutional investors. Book with your work email.
Hilleman Laboratories Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hilleman Laboratories's valuation, stock price, and market status.
Is Hilleman Laboratories a public or private company?
Hilleman Laboratories is a private company.
What is the current stock price of Hilleman Laboratories?
Hilleman Laboratories is a private company, so its shares have no public market price. Caplight tracks Hilleman Laboratories's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hilleman Laboratories worth (valuation)?
Valuation information for Hilleman Laboratories is not publicly available.
Can I buy Hilleman Laboratories stock?
Hilleman Laboratories shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hilleman Laboratories's last funding round?
Hilleman Laboratories's most recent funding round was Grant on January 22, 2026.
Who are the main investors in Hilleman Laboratories?
Key investors in Hilleman Laboratories include CEPI, Gates Foundation.
Will Hilleman Laboratories IPO soon?
No public IPO plans have been announced for Hilleman Laboratories.
How can I track Hilleman Laboratories secondary market activity?
Caplight tracks bids, offers, and trades in Hilleman Laboratories's shares on secondary markets.